1. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report. (1st March 2015) Authors: Sladden, M.; Zagarella, S.; Popescu, C.; Bigby, M. Journal: British journal of dermatology Issue: Volume 172:Number 3(2015:Mar.) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report. (March 2015) Authors: Sladden, M.; Zagarella, S.; Popescu, C.; Bigby, M. Journal: British journal of dermatology Issue: Volume 172:Number 3(2015:Mar.) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The sentinel node biopsy has not come of age. (1st February 2020) Authors: Sladden, M.; Zagarella, S.; Popescu, C.; Bigby, M. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The sentinel node biopsy has not come of age. (7th November 2019) Authors: Sladden, M.; Zagarella, S.; Popescu, C.; Bigby, M. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗